About Royal North Shore Hospital; Haematology Department
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eisai Inc.
2
Hoffmann-La Roche
2
Clinical Trials at Royal North Shore Hospital; Haematology Department
During the past decade, Royal North Shore Hospital; Haematology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients
1995-06-01
2006-12-01
Completed
195
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
1995-09-01
2006-12-01
Completed
86
A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
2016-03-09
2022-08-04
Completed
133
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation
2020-05-28
2025-06-28
Active, not recruiting
165
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Royal North Shore Hospital; Haematology Department
According to Clinical.Site data, the most researched conditions in "Royal North Shore Hospital; Haematology Department" are
"Lymphoma, T-Cell, Cutaneous" (2 trials), "Mycosis Fungoides" (2 trials), "Sezary Syndrome" (2 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Royal North Shore Hospital; Haematology Department" in a lesser frequency.
Clinical Trials Intervention Types at Royal North Shore Hospital; Haematology Department
Most popular intervention types in "Royal North Shore Hospital; Haematology Department" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "ONTAK" (2 trials), "Obinutuzumab" (2 trials), "Rituximab" (2 trials), "Venetoclax" (2 trials) and "Bendamustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Royal North Shore Hospital; Haematology Department
The vast majority of trials in "Royal North Shore Hospital; Haematology Department" are
4 trials for "All" genders.
Clinical Trials Status at Royal North Shore Hospital; Haematology Department
Currently, there are NaN active trials in "Royal North Shore Hospital; Haematology Department".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Royal North Shore Hospital; Haematology Department,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Royal North Shore Hospital; Haematology Department, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".